Neural Noise

Beinao-1 semi-invasive BMI demonstrated on a Beijing media tour (2026)

2 min read

  • Beinao-1 is described as a semi-invasive brain–machine interface (BMI) system presented during a media tour in Beijing.1
  • Coverage appeared via Reuters Connect and was indexed under Google News brain–machine interface topic aggregation.1
  • Available materials emphasize a press-style demonstration rather than peer-reviewed trial outcomes or published technical specifications in the briefing excerpt.1 1
  • The system is developed jointly by the Chinese Institute for Brain Research, Beijing (CIBR) and NeuCyber NeuroTech (Beijing) Co., Ltd., spun out of CIBR which was co-founded in 2018 by the Chinese Academy of Sciences, Peking University, and Tsinghua University.2
  • Beinao-1 features a 128-channel flexible electrode matrix placed epidurally (outside the dura mater), achieving the world’s highest signal throughput for a wireless, fully implanted, semi-invasive BCI; signal acquisition runs at 30 kHz with motion-intent decoding latency under 100 milliseconds.3
  • As of June 2026, the system has completed nearly 30 human implantations in the investigator-initiated trial phase and has entered registered clinical trials; the first implanted patient has used the device for over 15 months with stable recordings, and the system has accumulated over 65,000 hours of safe operation.4
  • Target patient populations include spinal cord injury, ALS, and stroke; demonstrated capabilities include fine motor decoding for paralyzed patients, mind-controlled robotic-arm operation, and speech decoding from a vocabulary of nearly 100 commonly used Chinese words.4
  • China’s government designated BMI/BCI a national strategic “future industry” in the 2026 Government Work Report and 15th Five-Year Plan (2026–2030); NeuCyber is backed by approximately $29 million in funding from the Beijing government.2
  • A first live-streamed Beinao-1 implantation surgery was performed at Beijing Tiantan Hospital on April 14, 2026, watched live by hundreds of experts at a national BCI clinical conference, highlighting China’s full-chain R&D independence.5
  • The companion Beinao-2 uses flexible microwire electrodes implanted into brain tissue for higher signal quality and is slated to enter clinical validation in the second half of 2026; the team plans to enroll all trial patients by end of 2026 and apply for a medical device registration certificate in 2027.4
  • Researchers reported an unexpected finding from trials: some patients showed partial motor function recovery during rehabilitation—beyond device-assisted control—suggesting potential therapeutic, not just assistive, effects.2

Footnotes

  1. https://news.google.com/rss/articles/CBMikAJBVV95cUxQSEN4V1ZkRlFpSDhOYkpZS2haam1uM3llOVYycTlTaFpDdEprdkxwTnN2bWtEemFmaWdhNnVxQU9EU0tNWmxETDR1Q2NOMkRlSjZHeUJTZHFudmZ5Wmh1dXJWb3ZnQjd1aXRHNWZyMDlMNjVWT09iZlRmc3pRdnZ4VGFqbC1SbG11YmtOS0JZbm4yTzByQ0FzVVltQjZ1Vk1wTXZEMHFxbERtUDJ2WTBsTExZVmNDZkNvX095Y1pCd3JEVXpjSWFDU0N6X2xoM1FCNWl4UnBjR3pBT2tyTGJkY3lsTHRHeUVNT3F0OG1WTEI4M3NjdmZhNUF5RkNQakpGa0FRYWNkVnduR0VGTXhWVA?oc=5 ↩ ↩2 ↩3 ↩4

  2. http://www.china.org.cn/2026-06/05/content_118533160.shtml ↩ ↩2 ↩3

  3. https://news.cgtn.com/news/2026-04-15/China-completes-first-live-streamed-Beinao-No-1-BCI-surgery-1MmwHSLYfQs/share_amp.html ↩

  4. https://global.chinadaily.com.cn/a/202606/15/WS6a2fc5cba310986e2b460147.html ↩ ↩2 ↩3

  5. https://global.chinadaily.com.cn/a/202604/14/WS69de15aaa310d6866eb435f5.html ↩

Graph View